Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation

• Status: Completed
• Trial end date: 2018-11-25
• Target enrollment: 0
• Participant gender: All

Summary

in our study the investigators aim to assess the effect of terlipressin on cerebral oxygenation monitored by cerebral oxymetry and cerebral blood flow measured by transcranial doppler.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kasr El Aini Hospital
• Treatments: Terlipressin

Criteria

Inclusion Criteria:

• ASA II-IV undergoing orthotopic liver transplantation.

• Age above 18 years.

Exclusion Criteria:

• Age below 18 years.

• Patients on Terlipressin preoperative.

• Patients known allergic to Terlipressin.

• Portal vein thrombosis.

• Ischemic heart disease.

• Patients with T. bilirubin level above 7 mg/dl